Potential role of 124I-girentuximab in the presurgical diagnosis of clear-cell renal cell cancer
Marc C Smaldone,1 David YT Chen,1 Jian Q Yu,2 Elizabeth R Plimack31Division of Urologic Oncology, 2Department of Diagnostic Imaging, 3Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, PA, USAAbstract: Renal cell carcinoma (RCC) is a biologically heterogeneous disease, with many...
Main Authors: | Plimack ER, Yu JQ, Chen DY, Smaldone MC |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2012-11-01
|
Series: | Biologics : Targets & Therapy |
Online Access: | http://www.dovepress.com/potential-role-of-124i-girentuximab-in-the-presurgical-diagnosis-of-cl-a11542 |
Similar Items
-
Early follow-up imaging after cryoablation of clear cell renal cell carcinoma is feasible using single photon emission computed tomography with ¹¹¹In-girentuximab
by: T.J. Van Oostenbrugge, et al.
Published: (2020-07-01) -
Evaluation of Radiolabeled Girentuximab In Vitro and In Vivo
by: Tais Basaco, et al.
Published: (2018-11-01) -
Successful Combination of Sunitinib and Girentuximab in Two Renal Cell Carcinoma Animal Models: A Rationale for Combination Treatment of Patients with Advanced RCC
by: Jeannette C. Oosterwijk-Wakka, et al.
Published: (2015-02-01) -
PET/CT imaging of clear cell renal cell carcinoma with 124I labeled chimeric antibody
by: Eamonn E. Bahnson, et al.
Published: (2009-06-01) -
Role of presurgical targeted molecular therapy in renal cell carcinoma with an inferior vena cava tumor thrombus
by: Peng C, et al.
Published: (2018-04-01)